- Staat
- MA
- Alter
- -
- Geschlecht
- U
- Eingang
- 06.10.2023
- Impfdatum
- -
- Beginn
- 04.10.2023
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE/PQC; An expired dose of VAQTA was inadvertently administered to the patient today 10/04/2023.; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. Information regarding the patient's medical history, concurrent conditions and concomitant medications was not reported. On an unknown date, the patient was vaccinated with an expired dose of hepatitis a vaccine, inactivated (VAQTA) for prophylaxis (lot number u036184, expiration date 02-MAR-2023) (strength, route of administration and anatomical location were not provided). No adverse event reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 08.05.2023
- Impfdatum
- 11.10.2022
- Beginn
- 18.01.2023
- Tage bis Beginn
- 99,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
No additional AEs or PQC reported; Caller states 1st dose was administered on 10/11/2022 and 2nd dose was administered on 1/18/2023.; This spontaneous report has been received from a medical assistant and refers to a 39-year-old male patient. The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported. On 11-OCT-2022, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 milliliter (ml). On 18-JAN-2023, being too early, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 milliliter (inappropriate schedule of product administration) (lot number reported for both doses U036184 has been determined to be valid for hepatitis a vaccine, inactivated (VAQTA), expiration date reported and established as 02-MAR-2023), both administered intramuscularly for prophylaxis (strength was not provided).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 08.05.2023
- Impfdatum
- 11.10.2022
- Beginn
- 18.01.2023
- Tage bis Beginn
- 99,0
- Dosis
- 2
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
No additional AEs or PQC reported; Caller states 1st dose was administered on 10/11/2022 and 2nd dose was administered on 1/18/2023.; This spontaneous report has been received from a medical assistant and refers to a 39-year-old male patient. The patient's pertinent medical history, other drug reactions or allergies, concurrent conditions and concomitant therapies were not reported. On 11-OCT-2022, the patient was vaccinated with the first dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 milliliter (ml). On 18-JAN-2023, being too early, the patient was vaccinated with the second dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 milliliter (inappropriate schedule of product administration) (lot number reported for both doses U036184 has been determined to be valid for hepatitis a vaccine, inactivated (VAQTA), expiration date reported and established as 02-MAR-2023), both administered intramuscularly for prophylaxis (strength was not provided).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- -
- Geschlecht
- U
- Eingang
- 21.04.2023
- Impfdatum
- 28.03.2023
- Beginn
- 28.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No Additional AE/PQC; HCP called in to inform patient received expired dose of VAQTA.; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, or medical history provided. On 28-MAR-2023, the patient was vaccinated with expired dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided) intramuscular injection, 1ml/x1, lot #U036184, expiration date: 02-MAR-2023, administered for prophylaxis (anatomical location and route of administration were not provided) (expired product administered). No additional adverse event (AE) reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- -
- Geschlecht
- U
- Eingang
- 20.04.2023
- Impfdatum
- 11.04.2023
- Beginn
- 11.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
no adverse event; Expired vaccine used; This spontaneous report was received from a medical assistant referred to a 41-year-old patient of unknown gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant therapies were not reported. On 11-APR-2023, the patient was vaccinated an expired dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 dose, lot #U036184, expiration date: 02-MAR-2023, for prophylaxis (strength, and route of administration were not provided) (Expired product administered). It was confirmed that no other adverse event occurred (no adverse event), and the product did not have any temperature excursions prior to administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- -
- Geschlecht
- U
- Eingang
- 19.04.2023
- Impfdatum
- 14.04.2023
- Beginn
- 14.04.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
No additional AEs reported; had a previous temperature excursion; expired vaccine was administered; This spontaneous report was received from a registered nurse and referred to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant therapies were not reported. On 14-APR-2023, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (strength: 50 dosage form, 1 mL, lot #U036184, expiration date: 02-MAR-2023, administered intramuscularly through deltoid (unspecified) for prophylaxis (expired product administered). The suspect vaccine had had a previous temperature excursion (product storage error). The detail of temperature excursion was not reported. No additional adverse event reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 10.04.2023
- Impfdatum
- 30.01.2023
- Beginn
- 30.01.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Product administered to patient of inappropriate age
Symptomtext
Gave wrong vaccine. Due to patient's age, they should have received pediatric dose, not adult dose. No adverse reactions noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- albuterol 90 mcg/actuation HFA inhaler multivitamin tablet
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 06.04.2023
- Impfdatum
- 29.03.2023
- Beginn
- 29.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Symptomtext
No adverse reaction reported to the clinic. No complaints from patient / no symptoms present
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 54,0
- Geschlecht
- F
- Eingang
- 06.04.2023
- Impfdatum
- 19.03.2023
- Beginn
- 19.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
None reported to the clinic
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- -
- Geschlecht
- U
- Eingang
- 29.03.2023
- Impfdatum
- 15.03.2023
- Beginn
- 15.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No additional AE reported.; HCP calling to report that a patient was administered an expired vaccine of VAQTA.; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions/allergies were not reported. On 15-MAR-2023, the patient was vaccinated an expired vaccine of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, 1 ml/ 1x (once), lot #U036184, expiration date: 02-MAR-2023, administered for prophylaxis (strength and route of administration were not provided) (expired product administered). No previous temperature excursion. No additional adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 20.03.2023
- Impfdatum
- 20.03.2023
- Beginn
- 20.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient was given a Hepatitis A (Vaqta) vaccine that expired on 03/02/2023.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- type 2 diabetes mellitus, essential hypertension, hypothyroidism, obstructive sleep apnea syndrome, asthma, hypercholesterolemia, insomnia, increased body mass index, bilateral knee pain, osteoarthritis, spasm of back muscles.
- Andere Medikamente
- acetaZOLAMIDE 125 mg tablet, Advair Diskus 250 mcg-50 mcg/dose powder for inhalation, Co Q-10, Curcumin, Flonase Allergy Relief, fosinopriL 20 mg tablet, levothyroxine 175 mcg tablet, magnesium 400 mg (as magnesium oxide) capsule, metaxalon
- Allergien
- blueberry, codeine, Neoprene, Penicillins.
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 10.03.2023
- Impfdatum
- 08.03.2023
- Beginn
- 08.03.2023
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
No adverse event
Symptomtext
Immunization given 3/8/23 but med expired 3/2/23. No adverse effects have been reported so far.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Diabetes, hypertension, chronic gastritis, pancreatitis, GERD, daily alcohol use, smoker, history of hepatitis C, history of CVA.
- Andere Medikamente
- Albuterol, Amlodipine, Aspirin, Atorvastatin, Chlorthalidone, Diclofenac, Ferrous Sulfate, Fluconazole, Gabapentin, Insulin Glargine, Lisinopril, Metformin, Nicotine patch, Omeprazole, Potassium Citrate
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- 27,0
- Geschlecht
- M
- Eingang
- 16.02.2023
- Impfdatum
- 14.02.2023
- Beginn
- 14.02.2023
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Medication error
No adverse event
Wrong product administered
Symptomtext
No adverse event. Med error. Bivalent Moderna given for dose # 2 in the primary series. Repeated with monovalent Modera per CDC guidelines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 10.11.2022
- Impfdatum
- 04.11.2022
- Beginn
- 04.11.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Patient received an adult dose of Hep A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Clindamycin ( External Solution)
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- -
- Geschlecht
- U
- Eingang
- 28.10.2022
- Impfdatum
- 27.09.2022
- Beginn
- 27.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
No adverse event
Symptomtext
No additional AE reported; pediatric patient (16 years old) was administered an adult dose of VAQTA.; This spontaneous report was received from a health care professional (HCP) referring to a 16-year-old patient of unknown gender ( reported as pediatric patient). The patient's concurrent conditions, medical history and concomitant therapies were not reported. On 27-SEP-2022, the patient received an adult dose of hepatitis a vaccine, inactivated (VAQTA) 50/1.0 U/mL, 1 milliliter, lot # U036184 and expiration date on 02-MAR-2023, administered for prophylaxis (dose number and route of administration were not provided) (Incorrect dose administered). No adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 17.10.2022
- Impfdatum
- 29.09.2022
- Beginn
- 29.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
No additional AE reported; A 12 month old pediatric patient was administered an adult dose of VAQTA; This spontaneous report has been received from a nurse practitioner, referring to a 12-month-old patient of unknown gender. The patient's medical history and concurrent conditions were not reported. Concomitant therapies were not reported. On 29-SEP-2022 the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) 1 dose (strength, route, and anatomical site of administration were not reported, lot number U036184, and expiration date 02-MAR-2023) as prophylaxis. The pediatric patient was administered with an adult dose (product administered to patient of inappropriate age). No additional AE reported (no adverse event). No PQC reported. The reporter gave consent for follow-up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 11.10.2022
- Impfdatum
- 07.10.2022
- Beginn
- 07.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Symptomtext
Patient was administered 0.5ml of pediatric Hepatitis A vaccine in a single dose vial then was administered 1.0ml of adult Hepatitis A vaccine in prefilled syringe.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- WI
- Alter
- 1,0
- Geschlecht
- U
- Eingang
- 07.10.2022
- Impfdatum
- 30.09.2022
- Beginn
- 30.09.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Incorrect dose administered
Product use issue
Symptomtext
No additional AE reported.; An adult dose of VAQTA was administered to a 1-year old patient on 30-SEP-2022.; An adult dose of VAQTA was administered to a 1-year old patient on 30-SEP-2022.; This spontaneous report was received from a pharmacist and refers to an 1-year-old patient. The patient's medical history, concomitant therapies and previous drugs reactions or allergies were not reported. On 30-SEP-2022, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) at a dose of 1 milliliter (Inappropriate dose of vaccine administered), lot #U036184, expiration date: 02-MAR-2023, administered for prophylaxis (strength, and route of administration were not provided) (Drug use in unapproved age group). No additional adverse event was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 03.10.2022
- Impfdatum
- 03.10.2022
- Beginn
- 03.10.2022
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SC / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
No adverse event
Symptomtext
child was administered the wrong dose of vaccine - no reactions
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Incorrect dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 62,0
- Geschlecht
- U
- Eingang
- 23.07.2022
- Impfdatum
- 01.01.2019
- Beginn
- 13.07.2022
- Tage bis Beginn
- 1.289,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
No additional AE.; Caller stated a 62 year old patient had a first dose of VAQTA in January 2019, but did not come back for the second dose until today, 13JUL2022.; This spontaneous report was received from a pharmacist and refers to a 62-year-old patient of unknown gender. The patient's medical history, concomitant therapies and concurrent conditions were not provided. On an unknown date in January 2019, the patient was vaccinated with a first dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection (dose, strength, route of administration, anatomical location, lot # and expiration date were not provided) for prophylaxis. On 13-JUL-2022, the patient was vaccinated with a second dose of hepatitis a vaccine, inactivated (VAQTA) intramuscular injection, prefilled syringe, 0.5 milliliter, lot # U036184, expiration date 02-MAR-2023 (strength, route of administration and anatomical location were not provided) for prophylaxis (inappropriate schedule of product administration). No additional adverse event was reported (no adverse event).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -